CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation. - Wikidata - awgldk - TriplyDB

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.

http://www.wikidata.org/entity/Q37127055

about

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.Multiple myeloma in the marrow: pathogenesis and treatments.Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.The Autophagy Machinery: A New Player in Chemotactic Cell Migration.Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.Microenvironment drug resistance in multiple myeloma: emerging new players.High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.MGUS to myeloma: a mysterious gammopathy of underexplored significance.Current treatment options of T cell-associated immunotherapy in multiple myeloma.Mechanisms of Resistance in Multiple Myeloma.Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction.Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma.Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.The bone-marrow niche in MDS and MGUS: implications for AML and MM.Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.3d Tissue Engineered In Vitro Models Of Cancer In Bone

P2860

Q33798887-D46F44B1-0E2A-430B-8E8E-F5367AC1A793 Q36725401-7037C18F-8534-4F56-8D24-402D4CFF514D Q37101382-4BEE1061-8BD9-41EA-A258-E39C62AA108F Q37541868-16CF776D-B7E6-45D3-AE92-372CD13452F2 Q37575786-A98511D8-A45A-48AF-ACDD-D9F859533BC9 Q37643901-96ADF8C1-5FB8-4A06-A6D5-11A3D7FB86DC Q38642842-767B11F7-4050-4DAC-8EBD-69C9549FBC87 Q38670431-7C54B636-AD4F-4525-BF36-3736A1E6F0E2 Q38758857-A30AE084-F1EC-4A88-B401-F56F7DABC882 Q38895512-459CFBB1-D14A-48F3-88DD-1C3DD703A6FD Q38913083-E3CA0FA3-C739-4C60-BA1A-30AB5308EDF3 Q38979403-15EE9153-2806-4B6E-AC42-12FC7AC1309E Q38979865-83599E5B-C4F7-4BEB-A5A7-E5976256A101 Q39102170-EA51174A-E8D0-40AA-A84E-076AFF2AB0D9 Q39185604-2BAE8DC8-5790-42D6-9089-7B5BF1ACF899 Q39375290-8E05883A-A20F-4510-A4A8-4A384F0AF486 Q41067901-3CBC8CE1-1392-4CF1-929A-87F4C5C17216 Q47708680-66E07207-7205-4D48-9B97-1EC9D6B161C8 Q48186628-AE36B13F-02CD-4E35-B8F3-47E8EA1DD552 Q48188365-3A8E42EC-24A8-4AC2-A669-2432B6EA61E4 Q48300802-CBB15E62-3242-4910-81A3-9BC5236CEC2C Q49539698-8901A882-E99B-4B59-AB2B-EA1C9D2CCB90 Q50114615-7B2887E2-7986-4ECB-AC7A-239E2165C842 Q50182712-FF711AF3-371F-45D5-978E-B78EC20C8550 Q51808808-E8093310-BDA3-4C78-B46F-380F7D6A3024 Q52665836-96992F16-6FC0-46D8-8FEF-5CBE531B77DE Q55354182-6D7F8028-5D55-410C-A928-15AB50385D67 Q57215522-242D59B9-F571-4C1D-A808-9CBB7AD94285

P2860

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.

http://www.wikidata.org/entity/Q37127055

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 July 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@en

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@nl

type

label

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@en

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@nl

prefLabel

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@en

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@nl

P1433

Q37127055-5E132403-1729-447F-89F4-650B1A6AB6D4

P1476

Q37127055-E94B1D88-5982-4F9D-94F4-29BCA49D5C40

P2093

Q37127055-148F56CF-71C1-422D-9292-932ADC7D2FFD

Q37127055-2B1F32C8-48CB-43D0-A8EC-CB39E68060E5

Q37127055-4326475E-4CE8-4364-8E37-24F32F3B9ACE

Q37127055-47A34764-CF1B-4D27-B9EF-EB26AF91669F

Q37127055-47C92475-EDC6-415C-8DCF-94CF03979118

Q37127055-49991FE3-1071-499B-8606-E72C2D6BF2A4

Q37127055-53F33FBD-D647-48F1-BF3F-6A6F0D47BB84

Q37127055-55626F54-679A-498F-BB5A-987BE3426F82

Q37127055-590594A7-4635-49B4-891A-745E2CA97B3F

Q37127055-66715296-2436-4A78-AE8D-38035C2FCA8B

P2860

Q37127055-0C2FF5A5-79EC-453E-839A-8492567B11D4

Q37127055-0E3C814C-C198-4558-A3AA-22D1FCA7D733

Q37127055-108FB574-1296-4749-A762-4CDB28B7BF70

Q37127055-204692A8-98D0-4F53-8D77-3EDD3AF75DA4

Q37127055-2284D4D7-5D7C-4796-918F-FE8453D48381

Q37127055-2AB84FB8-4E9C-4767-8DC8-BDBFC285C91B

Q37127055-3ED4CEF5-617C-4263-B405-CD6E3602F072

Q37127055-3EDBB922-C617-4E9A-BF45-355E6DBC7C3D

Q37127055-406C87B1-C397-4349-BB5A-9FFE55FF2532

Q37127055-43137090-9902-45B4-9136-4FE6E5E6B3E5

P304

Q37127055-3F7EB70F-C35F-48D2-A409-796193BE2B54

P31

Q37127055-6CE0E816-C0D0-4C66-8DD4-34E5ADE68C3F

P356

Q37127055-2C743A2C-6084-4498-BFFF-92CC5F2E9986

P433

Q37127055-66C81514-5173-49FE-AC7E-97D42060C2BA

P478

Q37127055-02A63DCE-DAA1-4BE8-9FCA-14CBC4FEC5A5

P50

Q37127055-01D19CC7-99B5-4510-8984-3BC0BFEC4404

Q37127055-18C5A71D-53FB-4BA5-A850-89D12292D9C2

Q37127055-18FC7D72-B8F1-47BB-AA31-8DB9CC4EE549

Q37127055-63445ADE-A517-4FC3-A51A-F55618137AE0

Q37127055-830DCB7C-C830-4271-AA01-89332B086879

Q37127055-E1CDEDFB-B7B8-4527-92EF-D1EB411843ED

P577

Q37127055-1EEB4F9E-8216-4892-859E-394366E14454

P698

Q37127055-FB9837D7-43B5-46DC-8CD2-CA71E022A78E

P932

Q37127055-BC30D016-185D-4466-9E11-11EF483B4A8D

P356

J.CELREP.2015.06.059

P1433

P1476

CXCR4 Regulates Extra-Medullar ...... ke Transcriptional Activation.

@en

P2093

Chin Pan

http://www.w3.org/2001/XMLSchema#string

Daisy Huynh

http://www.w3.org/2001/XMLSchema#string

Elizabeth Morgan

http://www.w3.org/2001/XMLSchema#string

Franziska Michor

http://www.w3.org/2001/XMLSchema#string

Ilyas Sahin

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

Jiantao Shi

http://www.w3.org/2001/XMLSchema#string

Michele Moschetta

http://www.w3.org/2001/XMLSchema#string

Michelle Kuhne

http://www.w3.org/2001/XMLSchema#string

Pina Cardarelli

http://www.w3.org/2001/XMLSchema#string

P2860

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

The Hallmarks of Cancer

Involvement of chemokine receptors in breast cancer metastasis

Epithelial-mesenchymal transition and its implications for fibrosis

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Epithelial-mesenchymal transitions in tumour progression

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

P304

622-635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2015.06.059

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Michaela R. Reagan

P577

2015-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26190113

http://www.w3.org/2001/XMLSchema#string

P932

4961259

http://www.w3.org/2001/XMLSchema#string